HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
VTRS
Viatris Inc.
VTRS lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
VTRS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Weak |
VTRS's cash flow is currently strong, and its revenue and profitability are stable, but its balance sheet is weak.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
VTRS PE Valuation
VTRS has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
VTRS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
VTRS has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over VTRS on earnings, with more consistent year-over-year improvement.
VTRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.65 | — |
| Q3 2026 | -$0.57 | +$2.52 |
| Q2 2026 | -$0.40 | +$2.50 |
| Q1 2026 | -$0.30 | +$2.87 |
| Q4 2025 | -$3.00 | -$2.47 |
| Q3 2025 | -$3.09 | -$2.36 |
| Q2 2025 | -$2.90 | -$2.36 |
| Q1 2025 | -$3.17 | -$3.12 |
| Q4 2024 | -$0.53 | -1160% |
VTRS is still losing money, but far less than before: $0.57 per share over the past year, against $3.17 at its worst in early 2025.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over VTRS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
VTRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | -0.3% |
| Q2 2026 | $3.8B | +4.9% |
| Q1 2026 | $3.5B | +8.1% |
| Q4 2025 | $3.7B | +5% |
| Q3 2025 | $3.8B | +0.2% |
| Q2 2025 | $3.6B | -5.6% |
| Q1 2025 | $3.3B | -11% |
| Q4 2024 | $3.5B | -8.1% |
VTRS's revenue is growing: $3.7B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7% | +2.2 points |
| Q2 2026 | 0.2% | -6.3 points |
| Q1 2026 | -2.3% | +86 points |
| Q4 2025 | -5.2% | -0.1 points |
| Q3 2025 | 4.8% | -1.3 points |
| Q2 2025 | 6.5% | +13 points |
| Q1 2025 | -89% | -94 points |
| Q4 2024 | -5.1% | +6.7 points |
VTRS has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over VTRS on cash flow, with more consistent year-over-year improvement.
VTRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $813.7M | +24% |
| Q2 2026 | $329M | +97% |
| Q1 2026 | $348.4M | -29% |
| Q4 2025 | $619.3M | +81% |
| Q3 2025 | $658.1M | -12% |
| Q2 2025 | $166.8M | -48% |
| Q1 2025 | $492.9M | -13% |
| Q4 2024 | $342.3M | +9% |
VTRS generated $2.1B in free cash flow over the past year, up 27% from the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over VTRS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
VTRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -14.7M shares |
| 1 year | -1.4% | -16M shares |
| 3 years | -4.3% | -51.1M shares |
| 5 years | -5.3% | -64M shares |
VTRS has 1.1B diluted shares, down 1.4% from a year ago, with $385M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $150M |
| Q2 2026 | $150M |
| Q1 2026 | — |
| Q4 2025 | $85.1M |
| Q3 2025 | $67.9M |
| Q2 2025 | $175M |
| Q1 2025 | $175.4M |
| Q4 2024 | — |
VTRS spent $385M buying back its own shares over the past year, down 7.9% from the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
VTRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.1x | High |
| Q2 2026 | 4.6x | High |
| Q1 2026 | 4.3x | High |
| Q4 2025 | 96.8x | High |
| Q3 2025 | 105.5x | High |
| Q2 2025 | 89.2x | High |
| Q4 2024 | 4.6x | High |
| Q3 2024 | 5.5x | High |
VTRS's net debt is about 4.1 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
VTRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.1 | Overbought |
| Stochastic | 92.0 | Overbought |
VTRS's weekly RSI is 73 (overbought) and its Stochastic is 92 (overbought).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
VTRS PE vs Healthcare Sector
| Metric | VTRS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
VTRS has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
VTRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.7 | 11% above |
| 20 week MA | $17.5 | 18% above |
| 50 week MA | $15.6 | 33% above |
| 100 week MA | $12.7 | 63% above |
| 200 week MA | $11.8 | 75% above |
VTRS has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
VTRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.7 | $17.8 | -9.9% |
| 2021 | $17.8 | $13.6 | -23% |
| 2022 | $13.6 | $11.0 | -19% |
| 2023 | $11.0 | $10.8 | -1.6% |
| 2024 | $10.8 | $12.5 | +15% |
| 2025 | $12.5 | $12.3 | -1.3% |
| 2026 YTD | $12.3 | $20.7 | +68% |
VTRS has the edge over HIMS on returns for 2026, with the stronger performance.